Do you really know your meds? new survey tests GATTEX safety smarts
NCT ID NCT05561647
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses a survey to see how well patients and doctors understand the risks and required checkups for the drug GATTEX, used to treat Short Bowel Syndrome. About 600 people—adults who have taken GATTEX in the last 60 days and their healthcare providers—will answer true/false questions online, by phone, or on paper. No study medicine is given; the goal is to make sure everyone knows how to use GATTEX safely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME (SBS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Takeda Pharmaceuticals, U.S.A., Inc.
RECRUITINGCambridge, Massachusetts, 02142, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a weekly injection ease the burden of short bowel syndrome?
- Gut bugs may boost bowel healing after short gut surgery
- Mini-Organs shed light on why some kids respond better to gut drug
- Could a common diabetes drug help heal the gut in short bowel syndrome?
- New hope for kids with short bowel: can a drug cut the need for IV feeding?
- New drug shows promise for managing short bowel syndrome Long-Term